Early Experiences With COVID-19 Testing in Transplantation
Brian J. Boyarsky(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Arthur D. Love(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Amber Kernodle(Brigham and Women's Hospital), Dorry L. Segev(New York University), Kyle R. Jackson(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Robin K. Avery(Johns Hopkins University), Patricia Niles(Mayville State University), Chad Trahan(Mayville State University), Michelle Altrich, Matthew Ronin(National Kidney Foundation), Jonathan Hewlett(Mayville State University), Alvin G. Thomas(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore)
Cited by 5
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k